DNA X: Lawrence W. Lytton reports 4.1% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DNA X, Inc. (SONM) reports that Lawrence W. Lytton beneficially owned 61,849 shares as of September 30, 2026. The reported total comprises 39,627 common shares and warrants to purchase 22,222 shares, and represented 4.1% of the class. The statement lists sole voting and dispositive power over 739 shares and shared voting and dispositive power over 61,110 shares. The 4.1% figure is based on 1,488,268 shares outstanding as of August 18, 2026.
Key Figures
Key Terms
beneficial ownership limitation financial
sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What voting and dispositive power did Lawrence W. Lytton report for SONM?
What limitation applies to Lawrence W. Lytton’s SONM warrants?
AI-generated analysis. How Rhea-AI works. Not financial advice.